title: Increased brain monoaminergic tone after the NMDA receptor GluN2A subunit gene knockout is responsible for resistance to the hypnotic effect of nitrous oxide.
abstract: N-methyl-d-aspartate (NMDA) receptors can be inhibited by inhalational anesthetics in vitro at clinically relevant concentrations. Here, to clarify the role of NMDA receptors in anesthetic-induced unconsciousness, we examined the hypnotic properties of isoflurane, sevoflurane and nitrous oxide in NMDA receptor GluN2A subunit knockout mice. The hypnotic properties of inhalational anesthetics were evaluated in mice in the loss of righting reflex (LORR) assay by measuring the 50% concentration for LORR (LORR ED(50)). Knockout mice displayed isoflurane and sevoflurane LORR ED(50) values similar to wild-type controls, indicating no significant contribution of these receptors to the hypnotic action of halogenated anesthetics. However, compared with wild-type controls, mutant mice displayed larger isoflurane LORR ED(50) values in the presence of nitrous oxide, indicating a resistance to this gaseous anesthetic. Knockout mice have enhanced brain monoaminergic activity which occurs secondary to NMDA receptor dysfunction, and the observed resistance to the isoflurane LORR ED(50)-sparing effect of nitrous oxide could be abolished by pretreatment with the dopamine D(2) receptor antagonist droperidol or with the serotonin 5-HT(2A) receptor antagonist ketanserin. Thus, resistance to nitrous oxide in knockout mice appears to be a secondary phenomenon of monoaminergic origin and not a direct result of impaired NMDA receptor function. Our results indicate that NMDA receptors are not critically involved in the hypnotic action of conventionally-used inhalational anesthetics. Also, they suggest that increased brain monoaminergic tone can diminish the effects of general anesthesia. Finally, they provide further evidence that changes secondary to genetic manipulation can explain the results obtained in global knockouts.
authors.affiliation: Division of Anesthesiology, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahi-machi, Chuo-ku, Niigata 951-8510, Japan. abpetr@med.niigata-u.ac.jp
authors.forename: Andrey B
authors.initials: AB
authors.lastname: Petrenko
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Yamakura
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Kohno
authors.forename: Kenji
authors.initials: K
authors.lastname: Sakimura
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Baba
mesh_terms: D000777:Anesthetics / Q000737:chemistry / Q000494:pharmacology; D000818:Animals; D015306:Biogenic Monoamines / Q000037:antagonists & inhibitors / Q000378:metabolism*; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D004329:Droperidol / Q000494:pharmacology; D004351:Drug Resistance / Q000235:genetics*; D055786:Gene Knockout Techniques; D054879:Halogenation; D006993:Hypnotics and Sedatives / Q000737:chemistry / Q000494:pharmacology; D007650:Ketanserin / Q000494:pharmacology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009609:Nitrous Oxide / Q000737:chemistry / Q000494:pharmacology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000172:deficiency* / Q000235:genetics*; D057897:Reflex, Righting / Q000187:drug effects; D014474:Unconsciousness / Q000139:chemically induced
chemical_list: D000777:Anesthetics; D015306:Biogenic Monoamines; D004329:Droperidol; D006993:Hypnotics and Sedatives; D007650:Ketanserin; D009609:Nitrous Oxide; D016194:Receptors, N-Methyl-D-Aspartate